Improving lung cancer screening through provider support and patient outreach
Provider Support and Patient Outreach in Lung Cancer Screening
This study is looking at ways to improve lung cancer screening by helping doctors and reaching out to patients, and it involves about 4,480 people who are eligible for screening to see if these efforts can encourage more people to get screened and make informed choices about their health.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Thomas Jefferson University NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10891380 on NIH RePORTER |
What this research studies
This research investigates how to enhance lung cancer screening by providing support to healthcare providers and reaching out to patients. It involves a randomized trial across four health systems, where primary care practices will be divided into groups receiving either support or outreach interventions. Approximately 4,480 patients eligible for lung cancer screening will be contacted to verify their eligibility and complete surveys. The study aims to understand the effectiveness of these interventions in promoting shared decision-making and increasing screening rates.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who are eligible for lung cancer screening and have scheduled primary care visits.
Not a fit: Patients who are not eligible for lung cancer screening or do not have access to the participating health systems may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved lung cancer screening rates, potentially catching the disease earlier and improving patient outcomes.
How similar studies have performed: Previous research has shown that provider support and patient outreach can significantly improve screening rates in various health contexts, suggesting a strong potential for success in this approach.
Where this research is happening
Philadelphia, United States
- Thomas Jefferson University — Philadelphia, United States (Active)
Researchers
- Principal investigator: Myers, Ronald E. — Thomas Jefferson University
- Study coordinator: Myers, Ronald E.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.